Snakebite envenoming represents an important Neglected Tropical Disease (NTD) that mainly affects tropical and subtropical developing countries according to the World Health Organization (WHO). As a priority issue in the tropics, it is estimated that accidental encounter between snakes and humans is the leading cause of morbidity and mortality among all NTDs in the world. In Brazil, an extremely diverse country with continental dimensions, snakebite envenoming is the second leading cause of reported human envenoming. Treating the disease has been an unprecedented challenge for Brazilian Health Systems for decades. Despite access to Antivenom therapy and distributing it free of charge across the country, Brazil faces numerous issues regarding the notification process and accurate treatment targeting for at-risk populations. Thus, this study aimed to identify the temporal epidemiological dynamics of accidents caused by Bothrops snakes in Brazil, the country’s major group of venomous snakes, based on secondary information from the online database provided by The Brazilian Notifiable Diseases Information System (SINAN). For this purpose, reported Bothrops snakebites between 2012 and 2021 were counted, then the data were analyzed. We looked at the frequency, occurrence, mortality rates, case fatality rate (CFR), age and gender distribution, and the time lapse between the incident and the initiation of Antivenom therapy. The data were also organized considering regional variations of the country. Throughout the studied period, a total of 202,604 cases of envenoming caused by Bothrops spp. were notified, resulting in 766 fatalities. These accidents were found to occur in variable proportions across different regions in Brazil, with notable concentrations observed in the North, Northeast, and Southeast regions. The epidemiological profile of patients varied greatly between the regions, revealing that snake envenoming is much more a social, economic, and ecological problem than a medical one. In conclusion, our study provides an overview of the clinical and epidemiological profile of envenoming by Bothrops snakes in Brazil. Notably, this is the first study to present such information in a country as vast and diverse as Brazil, encompassing a comparative analysis of its regions using SINAN data, that proves to be a very useful national tool to improve the control and management of envenoming.

Most infectious diseases affecting humans are zoonotic in origin, with mammals serving as the main reservoirs. Frequent interactions between humans and animals, especially in the context of their use for food, medicine, and other purposes, pose significant public health risks, as recently demonstrated by the SARS-CoV-2 pandemic. In traditional medicine, many species—some of which are also used as food—are valued for their therapeutic versatility, that is, the diversity of medicinal uses attributed to each species. This study investigates the role of zoonotic potential in the selection of mammals used in traditional medicine at a global scale. We compiled data on 411 wild mammal species across 17 orders, identifying 5.146 associated pathogens, of which 2.778 (53.9%) also infect humans. Most diseases transmitted by these species are caused by viruses (33.4%), bacteria (23.3%), and helminths (22.3%). These mammals are used to treat at least 500 diseases or symptoms, and 4.3% of the species show high therapeutic versatility (RI > 1). Our results indicate that species selection is shaped by both biological and cultural factors, with zoonotic potential being the most influential: species with a higher risk of disease transmission tend to be less used. These findings highlight the importance of incorporating zoonotic risk into research and policies regarding the medicinal use of wildlife.